Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Jeffrey John Thramann M.D. | Executive Chairman | 300k | -- | 1966 |
| Mr. Brent Ness | CEO, President & Director | 300k | -- | 1968 |
| Mr. John Lorbiecki | Chief Financial Officer | 225k | -- | 1964 |
| Mr. Ryan Bond | Chief Strategy Officer | 200k | -- | 1973 |
Aclarion, Inc.
- Sector:
- Healthcare
- Industry: Health Information Services
- Full Time Employees:
- 4
Description
Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. It develops NOCISCAN software application, a non-invasively analyze the chemical makeup of intervertebral discs in the spine. The company also develops NOCISCAN Post-Processor Suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available